by Morgan Pfeffer | Oct 24, 2019 | Uncategorized
Lawmakers in the U.S. House of Representatives are continuing work on their drug pricing bill, H.R. 3, with hopes of holding a vote later this month. Unveiled in September, H.R. 3 includes several provisions that would improve prescription drug access and...
by Morgan Pfeffer | Oct 24, 2019 | Uncategorized
Some changes are in store for Part D in 2020 and policymakers are contemplating even more. The Kaiser Family Foundation (KFF), a nonpartisan nonprofit focused on national health issues, recently outlined what the program will look like next year under current law, and...
